BRIDGEWATER, N.J., Nov. 2, 2020 /PRNewswire/ -- Insmed
Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases, today announced that management will present at the
following virtual investor conferences:
- The 29th Annual Credit Suisse Virtual Healthcare
Conference on Tuesday, November 10,
2020 at 3:30 p.m. ET
- The Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17, 2020 at 10:00 a.m. ET
Each fireside chat will be webcast live and can be accessed by
visiting the investor relations section of the company's website at
www.insmed.com. Each webcast will be archived for a period of 30
days following the conclusion of each live event.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product is a first-in-disease
therapy approved in the United
States and the European Union to treat a chronic,
debilitating lung disease. The Company is also progressing a robust
pipeline of investigational therapies targeting areas of serious
unmet need, including neutrophil-mediated inflammatory diseases and
rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing
footprint across Europe and in
Japan. For more information, visit
www.insmed.com.
Contact:
Investors:
Argot Partners
Laura Perry or Heather Savelle
(212) 600-1902
Insmed@argotpartners.com
Media:
Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/insmed-to-present-at-two-november-conferences-301164200.html
SOURCE Insmed Incorporated